NCT04282746View on ClinicalTrials.gov

A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

August 11, 2020

Study Completion Date

August 17, 2020

Conditions
Healthy
Interventions
DRUG

JNJ-54135419

Single dose of JNJ-54135419 oral solution will be administered sublingually.

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04282746 - A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants | Biotech Hunter | Biotech Hunter